Total Payments
$5,895
2024 Payments
$623.27
Companies
39
Transactions
313
Medicare Patients
4,577
Medicare Billing
$779,547
Payment Breakdown by Category
Food & Beverage$5,164 (87.6%)
Other$535.00 (9.1%)
Education$195.75 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,164 | 303 | 87.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $535.00 | 1 | 9.1% |
| Education | $195.75 | 9 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,890 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,222 | 59 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $549.11 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $503.40 | 36 | $0 (2022) |
| PFIZER INC. | $191.91 | 11 | $0 (2024) |
| Amgen Inc. | $184.78 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $163.75 | 9 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $121.64 | 7 | $0 (2024) |
| Radius Health, Inc. | $88.35 | 6 | $0 (2019) |
| Lilly USA, LLC | $70.46 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.27 | 33 | AstraZeneca Pharmaceuticals LP ($177.68) |
| 2023 | $639.74 | 42 | GlaxoSmithKline, LLC. ($228.98) |
| 2022 | $613.17 | 36 | AstraZeneca Pharmaceuticals LP ($193.00) |
| 2021 | $538.94 | 23 | GlaxoSmithKline, LLC. ($278.22) |
| 2020 | $193.53 | 14 | GlaxoSmithKline, LLC. ($85.21) |
| 2019 | $964.17 | 55 | GlaxoSmithKline, LLC. ($483.88) |
| 2018 | $577.34 | 43 | AstraZeneca Pharmaceuticals LP ($154.60) |
| 2017 | $1,745 | 67 | Circassia Pharmaceuticals Inc ($549.11) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $100.63 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: VACCINES | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Respiratory | ||||||
| 08/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Cardiology | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: VACCINES | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: VACCINES | ||||||
| 06/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: VACCINES | ||||||
| 06/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 05/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Respiratory | ||||||
| 05/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 04/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 984 | 5,213 | $270,935 | $203,449 |
| 2022 | 44 | 1,363 | 7,103 | $292,943 | $217,705 |
| 2021 | 33 | 1,085 | 5,094 | $199,959 | $155,669 |
| 2020 | 34 | 1,145 | 6,478 | $350,645 | $202,724 |
Total Patients
4,577
Total Services
23,888
Medicare Billing
$779,547
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 810 | $119,315 | $92,119 | 77.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 66 | 438 | $25,334 | $18,974 | 74.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 174 | $18,441 | $14,125 | 76.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 18 | 18 | $15,338 | $10,649 | 69.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 253 | $11,760 | $9,078 | 77.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 147 | $12,765 | $8,911 | 69.8% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 42 | 124 | $9,238 | $7,006 | 75.8% |
| 94644 | Inhalation treatment for acute airway obstruction, first hour | Office | 2023 | 19 | 100 | $7,355 | $5,734 | 78.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 29 | $5,894 | $4,648 | 78.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $3,429 | $3,347 | 97.6% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 12 | 12 | $3,150 | $3,034 | 96.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 15 | 16 | $3,838 | $2,902 | 75.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 189 | $3,058 | $2,425 | 79.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 15 | 15 | $3,617 | $2,215 | 61.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 13 | 77 | $2,874 | $2,079 | 72.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 32 | 37 | $2,635 | $1,987 | 75.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 32 | 37 | $2,402 | $1,893 | 78.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 15 | 17 | $2,460 | $1,768 | 71.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 24 | 24 | $2,262 | $1,756 | 77.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 32 | 38 | $2,096 | $1,376 | 65.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 13 | 13 | $1,337 | $937.44 | 70.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,154 | $924.84 | 80.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 11 | 44 | $1,133 | $835.12 | 73.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 24 | 24 | $708.48 | $690.96 | 97.5% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 32 | 37 | $789.21 | $514.30 | 65.2% |
About Dr. Deelip Chatterjee, M.D
Dr. Deelip Chatterjee, M.D is a Pulmonary Disease healthcare provider based in West Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790894707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deelip Chatterjee, M.D has received a total of $5,895 in payments from pharmaceutical and medical device companies, with $623.27 received in 2024. These payments were reported across 313 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,164).
As a Medicare-enrolled provider, Chatterjee has provided services to 4,577 Medicare beneficiaries, totaling 23,888 services with total Medicare billing of $779,547. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location West Paterson, NJ
- Active Since 08/30/2006
- Last Updated 03/03/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1790894707
Products in Payments
- TRELEGY ELLIPTA (Drug) $672.73
- BREZTRI (Drug) $540.34
- NIOX VERO (Device) $535.00
- ANORO (Drug) $511.41
- SYMBICORT (Drug) $371.28
- ANORO ELLIPTA (Drug) $369.47
- SPIRIVA RESPIMAT (Drug) $154.18
- OFEV (Drug) $134.57
- STIOLTO (Drug) $123.62
- OPSUMIT (Drug) $121.64
- AIRSUPRA (Drug) $104.15
- NUCALA (Biological) $99.66
- PREVNAR 20 (Biological) $99.20
- STIOLTO RESPIMAT (Drug) $91.03
- Tymlos (Biological) $88.35
- FASENRA (Drug) $86.77
- BREO (Drug) $85.35
- Enbrel (Biological) $71.59
- EVENITY (Biological) $71.51
- TRULICITY (Drug) $70.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.